Skip to main content

MDCT Staging of Disease Extent in Patients with Systemic Sclerosis: A Pilot Study

مؤلف البحث
A.M. Ghandour, R. M Gamal, G.S. Seifeldein, M. M M Galal, E.M. El-Hakeim
مجلة البحث
Annals of the Rheumatic Diseases
المشارك في البحث
الناشر
BMJ
تصنيف البحث
3
عدد البحث
74 (suppl. 2)
موقع البحث
https://ard.bmj.com/content/74/Suppl_2/601.3
سنة البحث
2015
صفحات البحث
601
ملخص البحث

Interstitial lung disease (ILD) is the leading cause of systemic sclerosis (SSc) related morbidity and mortality,surpassing scleroderma renal crisis, which has become a rarity following the advent of angiotensin-converting-enzyme (ACE) inhibitors.High resolution computed tomography (HRCT) is the gold standard for diagnosis of in systemic sclerosis (SSc) related interstitial lung disease (SSc-ILD).